ASX - By Stock
|
BCT |
Re:
Ann: Bluechiip Announces Equity Raising of up to $4.8m
|
|
geofftn
|
52 |
13K |
5 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
52
|
13K
|
5
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Bluechiip Announces Equity Raising of up to $4.8m
|
|
geofftn
|
52 |
13K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
52
|
13K
|
2
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing
|
|
geofftn
|
78 |
20K |
1 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
78
|
20K
|
1
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing
|
|
geofftn
|
78 |
20K |
0 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
78
|
20K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Happy Holidays
|
|
geofftn
|
42 |
15K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
42
|
15K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
geofftn
|
315 |
154K |
0 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
154K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing
|
|
geofftn
|
78 |
20K |
5 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
78
|
20K
|
5
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Bluechiip adds third top-20 global pharma to customer list
|
|
geofftn
|
17 |
4.5K |
0 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
17
|
4.5K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
|
|
geofftn
|
51 |
27K |
7 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
51
|
27K
|
7
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
geofftn
|
1.5K |
792K |
16 |
10/11/23 |
10/11/23 |
Charts
|
1.5K
|
792K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
4 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
4
|
|
Charts
|
PAB |
Re:
PABO vs PABOA
|
|
geofftn
|
34 |
10K |
3 |
14/10/23 |
14/10/23 |
Charts
|
34
|
10K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
8 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share price very undervalued still !!!
|
|
geofftn
|
49 |
23K |
0 |
23/09/23 |
23/09/23 |
ASX - By Stock
|
49
|
23K
|
0
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
geofftn
|
1.5K |
792K |
8 |
01/09/23 |
01/09/23 |
Charts
|
1.5K
|
792K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
4 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
4
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing
|
|
geofftn
|
57 |
13K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
57
|
13K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing
|
|
geofftn
|
57 |
13K |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
57
|
13K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
2 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
5 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
5
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
geofftn
|
5 |
2.1K |
0 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
5
|
2.1K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
8 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
8
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
geofftn
|
348 |
127K |
3 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
348
|
127K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor Presentation, 14 March 2023
|
|
geofftn
|
145 |
69K |
5 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
145
|
69K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
geofftn
|
163 |
80K |
6 |
26/02/23 |
26/02/23 |
ASX - By Stock
|
163
|
80K
|
6
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
geofftn
|
1.5K |
792K |
6 |
06/02/23 |
06/02/23 |
Charts
|
1.5K
|
792K
|
6
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
1 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
55
|
16K
|
1
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
55
|
16K
|
2
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
55
|
16K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
55
|
16K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
1 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
55
|
16K
|
1
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
55
|
16K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
0 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
55
|
16K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
Growth this quarter
|
|
geofftn
|
55 |
16K |
2 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
55
|
16K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
1 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
9.6K
|
4.3M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
10 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
9.6K
|
4.3M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
2 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
9.6K
|
4.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Acadia - Catalysts Stacking
|
|
geofftn
|
42 |
25K |
1 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
42
|
25K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Acadia - Catalysts Stacking
|
|
geofftn
|
42 |
25K |
5 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
42
|
25K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
|
|
geofftn
|
125 |
42K |
5 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
125
|
42K
|
5
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Appendix 4D & Half Year Financial Report
|
|
geofftn
|
13 |
5.5K |
1 |
05/03/22 |
05/03/22 |
ASX - By Stock
|
13
|
5.5K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
16 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
9.6K
|
4.3M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
geofftn
|
9.6K |
4.3M |
11 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
9.6K
|
4.3M
|
11
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Open Briefing
|
|
geofftn
|
76 |
17K |
3 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
76
|
17K
|
3
|
|
ASX - By Stock
|
BCT |
Re:
Ann: 2021 Annual General Meeting Date
|
|
geofftn
|
10 |
3.2K |
3 |
10/10/21 |
10/10/21 |
ASX - By Stock
|
10
|
3.2K
|
3
|
|
ASX - By Stock
|
BCT |
Re:
Ann: FY21 Annual Report
|
|
geofftn
|
20 |
4.9K |
0 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
20
|
4.9K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Updated MST report - target of $3.68 a share
|
|
geofftn
|
219 |
109K |
2 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
219
|
109K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 3 enrolment successfully completed, results in Q4 2021
|
|
geofftn
|
98 |
50K |
9 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
98
|
50K
|
9
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
geofftn
|
244 |
74K |
2 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
244
|
74K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
geofftn
|
244 |
74K |
7 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
244
|
74K
|
7
|
|